Concepedia

Jianing Li

JL

33

Publications

1.2K

Citations

23

H-Index

2009

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Second Affiliated Hospital of Harbin Medical University

Harbin Medical University

Shandong First Medical University

Shanghai Jiao Tong University

Jianing Li is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2009–2024

33

Publications

33

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

Helen Stacey, Jeffrey B. Rosen, James T. Peterson et al. · Human Vaccines & Immunotherapeutics · 2019 · 108 citations · Full text

Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial

Heather Platt, Tosin Omole, José F. Cardona et al. · The Lancet Infectious Diseases · 2022 · 79 citations

, , +9

International study of medical school learning environments and their relationship with student well‐being and empathy

Sean Tackett, Scott M. Wright, Robert Lubin et al. · Medical Education · 2016 · 78 citations

Checking Fine and Gray subdistribution hazards model with cumulative sums of residuals

Jianing Li, Thomas Scheike, Mei‐Jie Zhang · Lifetime Data Analysis · 2014 · 67 citations · Full text

, ,

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Heather Platt, David Greenberg, Bruce Tapiéro et al. · The Pediatric Infectious Disease Journal · 2020 · 63 citations · Full text

Rows per page

1–5 of 33